[1] SAWANT DV, HAMILTON K, VIGNALI DA, et al.Interleukin-35:expanding its job profile[J].J Interferon Cytokine Res, 2015, 35(7):499. doi: 10.1089/jir.2015.0015
[2] THIOLAT A, DENYS A, PETIT M, et al.Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice[J].Cytokine, 2014, 69(1):87.
[3] WANG RX, YU CR, DAMBUZA IM, et al.Interleukin-35 induces regulatory B cells that suppress autoimmune disease[J].Nat Med, 2014, 20(6):633. doi: 10.1038/nm.3554
[4] ZHANG YL, ZHOU XY, GUO XY, et al.Association between serum interleukin-35 levels and severity of acute pancreatitis[J].Int J Clin Exp Med, 2015, 8(5):7430.
[5] FILKOVA M, VEMEROVA Z, HULEJOVA H, et al.Pro-in Tammatory effects of interleukin-35 in rheumatoid arthritis[J].Cytokine, 2015, 73(1):36.
[6] KOSEOGLU S, SAGLAM M, PEKBAGRIYANIK T, et al.Level of interleukin-35 ingingival crevicular Tuid, saliva, and plasma in periodontal disease and health[J].J Periodontol, 2015, 86(8):964. doi: 10.1902/jop.2015.140666
[7] DING LF, CHEN Q, LI L, et al.Effects of sublingual immunotherapy on serum IL-17 and IL-35 levels in children with allergic rhinitis or asthma[J].Zhongguo Dang Dai Er Ke Za Zhi, 2014, 16(12):1206.
[8] COLLISON LW, PILLAI MR, CHATURVEDI V, et al.Regulatory T cell suppression is potentiated by target T cells in a cell contact:IL-35-and IL-10-dependent manner[J].J Immunol, 2009, 182(10):6121. doi: 10.4049/jimmunol.0803646
[9] COLLISON LW, WORKMAN CJ, KUO TT, et al.The inhibitory cytokine IL-35 contributes to regulatory T-cell function[J].Nature, 2007, 450(7169):566. doi: 10.1038/nature06306
[10] TIAN X, TIAN X, HUO R, et al.Bacillus Calmette-Guerin alleviates airway inflammation and remodeling by preventing TGF-beta1 induced epithelial-mesenchymal transition[J].Hum Vaccin Immunother, 2017, 13(8):1758. doi: 10.1080/21645515.2017.1313366
[11] MOHAMMADI SV, REZAEI A, ANDALIB A, et al.Immunomodulatory effects of adjuvants CPG, MPLA, and BCG on the Derp2-induced acute asthma at early life in an animal model of BALB/c mice[J].Inflammation, 2017, 40(1):259.
[12] KOWALEWICZ KM, LOCHT C.BCG and protection against inflammatory and auto-immune diseases[J].Expert Rev Vaccines, 2017, 16(7):1.
[13] SOUZA MA, CRUZ AA.BCG vaccination and reduced risk of asthma[J].J Bras Pneumol, 2010, 36(3):275. doi: 10.1590/S1806-37132010000300001
[14] CUI Y, CHOI IS, KOH YA, et al.Effects of combined BCG and DHEA treatment in preventing the development of asthma[J].Immunol Invest, 2008, 37(3):191.
[15] KE X, HUANG J, CHEN Q, et al.Protective effects of combined Mycobacterium bovis BCG and interleukin-12 vaccination on airway inflammation in a murine model of allergic asthma[J].Clin Invest Med, 2010, 33(3):196. doi: 10.25011/cim.v33i3.13726
[16] DENG Y, LI W, LUO Y, et al.Inhibition of IFN-gamma promotes anti-asthma effect of Mycobacterium bovis Bacillus Calmette-Guerin neonatal vaccination:a murine asthma model[J].Vaccine, 2014, 32(18):2070. doi: 10.1016/j.vaccine.2014.02.007
[17] HOU C, WU Q, OUGYANG C, et al.Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-infl ammatory and anti-infl ammatory cytokines[J].Int J Mol Med, 2016, 38(3):713. doi: 10.3892/ijmm.2016.2688
[18] 邓昱.IL-12+重组卡介苗新生期接种干预实验性哮喘模型的作用及其机制研究[D].重庆: 重庆医科大学, 2010.
[19] CASTELLANI ML, ANGEIANAKI A, FELACO P, et al.IL-35, an antiinflammatory cytokine which expands CD4+CD25+ Treg cells[J].J Biol Regul Homeost Agents, 2010, 24(2):131.
[20] TARIQUE M, SAINI C, NAQVI RA, et al.Increased IL-35 producing Tregs and CD19+IL-35+ cells are associated with disease progression in leprosy patients[J].Cytokine, 2017, 91:82. doi: 10.1016/j.cyto.2016.12.011
[21] SHEN H, WANG C, FAN E, et al.Upregulation of interleukin-35 subunits in regulatory T cells in a IL-35 alleviates lipopolysaccharide-Induced acute kidney injury murine model of allergic rhinitis[J].J Otorhinolaryngol, 2014, 76(5):237.
[22] ZHAO N, LI H, YAN Y, et al.Mesenchymal stem cells overexpressing IL-35 effectively inhibit CD4+ T cell function[J].Cellular Immunology, 2017, 312:61. doi: 10.1016/j.cellimm.2016.12.001
[23] NIEDBALA W, WEI XQ, CAI B, et al.IL-35 is a novel cytokine withtherapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells[J].Eur J Immunol, 2007, 37(11):3021. doi: 10.1002/eji.200737810
[24] ZHANG F, LI MY, LAN YT, et al.Imbalance of Th17/Tregs in rats with smoke inhalation-induced acute lung injury[J].Sci Rep, 2016, 6:21348. doi: 10.1038/srep21348
[25] JIANG S, LI Y, LIN T, et al.IL-35 inhibits angiogenesis through VEGF/Ang2/Tie2 pathway in rheumatoid arthritis[J].Cellular Physiol Biochemistry, 2016, 40(5):1105. doi: 10.1159/000453165
[26] HU L, CHEN C, ZHANG J, et al.IL-35 pretreatment alleviates lipopolysaccharide-induced acute kidney injury in mice by inhibiting NF-κB activation[J].Inflammation, 2017, 40(4):1393.
[27] ZHANG B, LIU Y, LAN X, et al.Oral escherichia coli expressing IL-35 meliorates experimental colitis in mice[J].J Transl Med, 2018, 16(1):71.
[28] 李忠明.当代新疫苗[M].北京:高等教育出版社, 2001:93.
[29] 沈雪艳, 陈三妹, 陈小萍, 等.新生期卡介苗和乙肝疫苗联合接种对哮喘小鼠IFN-γ、IL-4和IL-17A表达的影响[J].中国病理生理杂志, 2018, 34(3):515. doi: 10.3969/j.issn.1000-4718.2018.03.022
[30] 闻玉梅.治疗性疫苗的研究进展[J].中华微生物学和免疫学杂志, 1996, 16(3):155.
[31] NASCIMENTO IP, DIAS WO, QUINTILIO W, et al.Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge[J].Microbes Infect, 2008, 10(2):198. doi: 10.1016/j.micinf.2007.10.010
[32] 王秋悦.柔嫩艾美耳球虫rhomboid基因重组卡介苗的构建及其免疫保护性研究[D].长春: 吉林大学, 2009.